Stay updated on Omalizumab in Multi-Allergen OIT Clinical Trial
Sign up to get notified when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.

Latest updates to the Omalizumab in Multi-Allergen OIT Clinical Trial page
- CheckyesterdayChange DetectedThe page adds recruitment-status text and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating the Intervention/Treatment label and the revision/version from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check8 days agoChange DetectedThe page revision history shows a new revision entry v3.5.5 added and the previous v3.5.4 removed, signaling an update to the page's documents or metadata.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4. This indicates a minor update to the page build/metadata without changing study details.SummaryDifference0.0%

- Check51 days agoChange DetectedThe ClinicalTrials.gov page’s footer revision/version number was updated from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check87 days agoChange DetectedWebsite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check101 days agoChange DetectedThe page now shows Revision: v3.4.3 and the previous Revision: v3.4.2 label has been removed.SummaryDifference0.0%

Stay in the know with updates to Omalizumab in Multi-Allergen OIT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.